In Cancer, Pshezhetskiy and colleagues present: the Prostate Screening EpiSwitch (PSE) test, which combines the PSA test with epigenetic testing. Combining the PSA test with epigenetic testing “Only about a quarter of people who have a prostate biopsy due to an elevated PSA level are found to have prostate cancer.”ĭeveloping a new blood test that has greater accuracy, and is also non-invasive and inexpensive, is a focus for researchers. “There is currently no single test for prostate cancer, but PSA blood tests are among the most used, alongside physical examinations, MRI scans and biopsies,” says Professor Dmitry Pshezhetskiy from UEA’s Norwich Medical School.
Subscribe to Technology Networks’ daily newsletter, delivering breaking science news straight to your inbox every day.
